RiverVest Venture Management LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed July 24, 2024), RiverVest Venture Management LLC reported 4 stock positions worth $6.8 million. Its top holding was Reneo Pharmaceuticals at 56.1% of the portfolio, followed by Spruce Biosciences (SPRB, 22.3%) and Xilio Therapeutics (XLO, 20.0%). Its holdings were unchanged from Q1 2024.
- Most Recent 13F
- Q3 2024
- Location
- St. Louis, MO
- CIK
- 0001812549
- Portfolio Value
- $6.8M (Q2 2024)
- SEC Filing
- 0001104659-24-082340 ↗ filed Jul 24, 2024
Holdings Value
Holdings 4 stocks · $6.8M
| RENEO PHARMACEUTICALS INC | 56.07% | 2,534,220 | $3.8M | No change |
| SPRB Spruce Biosciences Inc. | 22.27% | 2,936,281 | $1.5M | No change |
| XLO Xilio Therapeutics Inc. | 20.01% | 1,441,444 | $1.4M | No change |
| VAPOTHERM INC | 1.65% | 52,881 | $112K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| None this quarter. | |||
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||